By controlling a molecular switch, scientists could potentially make aggressive cancers more sensitive to conventional drugs and improve treatment outcomes, say researchers.
By controlling a molecular switch, scientists could potentially make aggressive cancers more sensitive to conventional drugs and improve treatment outcomes, say researchers.